[Clinical analysis of drug eruption due to iohexol (Omnipaque)].
We reported 7 cases of drug eruption due to Iohexol (Omnipaque) which was nonionic X-ray contrast agent without severe adverse reaction. They showed generalized edematous and erythematous plaques. The eruption appeared from 5 to 6 days after the examination when a patient had not been sensitized, or several hours after that when he/she had been already sensitized. No case showed any cross-sensitization with ionic contrast media, but some cases suggested the possibility of cross-sensitization among the nonionic contrast agents.
Akiyama
M
M
Department of Dermatology, Showa University School of Medicine.
Iijima
M
M
Fujisawa
R
R
D000328:Adult; D000368:Aged; D003429:Cross Reactions; D003875:Drug Eruptions / Q000209:etiology* / Q000276:immunology; D000939:Epitopes; D005260:Female; D006801:Humans; D007428:Intradermal Tests; D007472:Iohexol / Q000009:adverse effects* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D010328:Patch Tests
D000939:Epitopes; D007472:Iohexol